Core Laboratories (NYSE:CLB) Posts Earnings Results, Hits Estimates

Core Laboratories (NYSE:CLBGet Free Report) posted its quarterly earnings results on Wednesday. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23, Zacks reports. Core Laboratories had a return on equity of 16.43% and a net margin of 5.99%. Core Laboratories updated its Q1 2025 guidance to 0.120-0.160 EPS.

Core Laboratories Stock Down 2.7 %

Shares of NYSE:CLB traded down $0.48 during trading on Friday, hitting $17.28. 55,322 shares of the company’s stock traded hands, compared to its average volume of 283,060. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. The company has a 50-day moving average price of $18.94 and a 200-day moving average price of $19.48. Core Laboratories has a 52 week low of $13.82 and a 52 week high of $25.13. The company has a market cap of $811.06 million, a price-to-earnings ratio of 26.18, a price-to-earnings-growth ratio of 1.09 and a beta of 2.39.

Core Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Monday, February 10th will be issued a $0.01 dividend. The ex-dividend date is Monday, February 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.23%. Core Laboratories’s dividend payout ratio (DPR) is currently 6.06%.

Analyst Ratings Changes

Several research firms have weighed in on CLB. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Citigroup reduced their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research note on Thursday, October 31st. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $17.00.

Get Our Latest Research Report on Core Laboratories

Core Laboratories Company Profile

(Get Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

Further Reading

Earnings History for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.